nile Antibody
nile Antibody
West Nile Virus Antibody |
|||
GWB-376E67 | GenWay Biotech | 0.1 mg | Ask for price |
West Nile Virus Antibody |
|||
GWB-4D0204 | GenWay Biotech | 0.1 mg | Ask for price |
West Nile Virus Antibody |
|||
GWB-B704DB | GenWay Biotech | 0.1 mg | Ask for price |
West Nile Virus Antibody |
|||
GWB-E45DB2 | GenWay Biotech | 0.1 mg | Ask for price |
West Nile Virus (WNV) Antibody |
|||
abx412023-01mg | Abbexa | 0.1 mg | 610.8 EUR |
West Nile Virus (WNV) Antibody |
|||
abx412023-100g | Abbexa | 100 µg | 537.5 EUR |
Human WEST NILE ANTIBODY,IGG ELISA KIT |
|||
ED0071Hu | Jiaxing Korain Biotech Ltd (BT Labs) | 96 wells | 458 EUR |
Human WEST NILE ANTIBODY,IGM ELISA KIT |
|||
ED0072Hu | Jiaxing Korain Biotech Ltd (BT Labs) | 96 wells | 458 EUR |
Human WEST NILE ANTIBODY, IGG ELISA Kit |
|||
MBS1610443-10x96StripWells | MyBiosource | 10x96-Strip-Wells | 3460 EUR |
Human WEST NILE ANTIBODY, IGG ELISA Kit |
|||
MBS1610443-5x96StripWells | MyBiosource | 5x96-Strip-Wells | 1750 EUR |
Human WEST NILE ANTIBODY, IGG ELISA Kit |
|||
MBS1610443-96StripWells | MyBiosource | 96-Strip-Wells | 425 EUR |
Human WEST NILE ANTIBODY, IGM ELISA Kit |
|||
MBS1610446-10x96StripWells | MyBiosource | 10x96-Strip-Wells | 3460 EUR |
Human WEST NILE ANTIBODY, IGM ELISA Kit |
|||
MBS1610446-5x96StripWells | MyBiosource | 5x96-Strip-Wells | 1750 EUR |
Human WEST NILE ANTIBODY, IGM ELISA Kit |
|||
MBS1610446-96StripWells | MyBiosource | 96-Strip-Wells | 425 EUR |
Human WEST NILE ANTIBODY,IGG ELISA KIT |
|||
JOT-EKD0071Hu | Jotbody | 96 wells | 366.4 EUR |
Description: Human |
|||
Human WEST NILE ANTIBODY,IGM ELISA KIT |
|||
JOT-EKD0072Hu | Jotbody | 96 wells | 366.4 EUR |
Description: Human |
|||
West Nile Virus Core Antibody |
|||
24281 | SAB | 100ul | 479 EUR |
West Nile Virus Core Antibody |
|||
24281-100ul | SAB | 100ul | 468 EUR |
West Nile Virus Core Antibody |
|||
3435-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Core Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins which play a major role for WNV entry into target cells. The viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway as delivery of core gene delivery into the striatum of mouse brain and skeletal muscle resulted in cell death and inflammation. |
|||
West Nile Virus Core Antibody |
|||
3435-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Core Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins which play a major role for WNV entry into target cells. The viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway as delivery of core gene delivery into the striatum of mouse brain and skeletal muscle resulted in cell death and inflammation. |
|||
West Nile Virus Core Antibody |
|||
MBS9413163-01mL | MyBiosource | 0.1mL | 495 EUR |
West Nile Virus Core Antibody |
|||
MBS9413163-5x01mL | MyBiosource | 5x0.1mL | 2075 EUR |
West Nile Virus Core Antibody |
|||
MBS150601-01mg | MyBiosource | 0.1mg | 445 EUR |
West Nile Virus Core Antibody |
|||
MBS150601-5x01mg | MyBiosource | 5x0.1mg | 1965 EUR |
West Nile Virus Matrix Antibody |
|||
24278 | SAB | 100ul | 479 EUR |
West Nile Virus Matrix Antibody |
|||
24278-100ul | SAB | 100ul | 468 EUR |
West Nile Virus Matrix Antibody |
|||
24279 | SAB | 100ul | 479 EUR |
West Nile Virus Matrix Antibody |
|||
24279-100ul | SAB | 100ul | 468 EUR |
West Nile Virus Matrix Antibody |
|||
3429-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Matrix Antibody |
|||
3429-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Matrix Antibody |
|||
3431-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Matrix Antibody |
|||
3431-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Matrix Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. However, when the viruses are inside of infected cells, the matrix protein exists in its "pre-M" form as a heterodimer with the envelope proteins. Cleavage of the "pre-M" protein to its mature form occurs during release of the virus; this cleavage leas to the dissociation of the heterodimers. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Matrix Antibody |
|||
MBS9408970-01mL | MyBiosource | 0.1mL | 495 EUR |
West Nile Virus Matrix Antibody |
|||
MBS9408970-5x01mL | MyBiosource | 5x0.1mL | 2075 EUR |
West Nile Virus Matrix Antibody |
|||
MBS9414400-01mL | MyBiosource | 0.1mL | 495 EUR |
West Nile Virus Matrix Antibody |
|||
MBS9414400-5x01mL | MyBiosource | 5x0.1mL | 2075 EUR |
West Nile Virus Matrix Antibody |
|||
MBS150911-01mg | MyBiosource | 0.1mg | 445 EUR |
West Nile Virus Matrix Antibody |
|||
MBS150911-5x01mg | MyBiosource | 5x0.1mg | 1965 EUR |
West Nile Virus Matrix Antibody |
|||
MBS151132-01mg | MyBiosource | 0.1mg | 445 EUR |
West Nile Virus Matrix Antibody |
|||
MBS151132-5x01mg | MyBiosource | 5x0.1mg | 1965 EUR |
West Nile Virus Envelope Antibody |
|||
24282 | SAB | 100ul | 479 EUR |
West Nile Virus Envelope Antibody |
|||
24282-100ul | SAB | 100ul | 468 EUR |
West Nile Virus Envelope Antibody |
|||
24283 | SAB | 100ul | 479 EUR |
West Nile Virus Envelope Antibody |
|||
24283-100ul | SAB | 100ul | 468 EUR |
West Nile Virus Envelope Antibody |
|||
24284 | SAB | 100ul | 479 EUR |
West Nile Virus Envelope Antibody |
|||
24284-100ul | SAB | 100ul | 468 EUR |
West Nile Virus Envelope Antibody |
|||
3437-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3437-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3439-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3439-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3441-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
3441-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: West Nile Virus Envelope Antibody: West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins. While the viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway, the highly glycosylated envelope protein plays a major role for WNV entry into target cells as this entry can be inhibited by using a recombinant domain III from the envelope glycoprotein. The WNV receptor has recently been identified as alpha v beta 3 integrin. |
|||
West Nile Virus Envelope Antibody |
|||
MBS9402248-01mL | MyBiosource | 0.1mL | 495 EUR |
West Nile Virus Envelope Antibody |
|||
MBS9402248-5x01mL | MyBiosource | 5x0.1mL | 2075 EUR |
West Nile Virus Envelope Antibody |
|||
MBS9404327-01mL | MyBiosource | 0.1mL | 495 EUR |
West Nile Virus Envelope Antibody |
|||
MBS9404327-5x01mL | MyBiosource | 5x0.1mL | 2075 EUR |
West Nile Virus Envelope Antibody |
|||
MBS9414904-01mL | MyBiosource | 0.1mL | 495 EUR |
West Nile Virus Envelope Antibody |
|||
MBS9414904-5x01mL | MyBiosource | 5x0.1mL | 2075 EUR |
West Nile Virus Envelope Antibody |
|||
MBS150612-01mg | MyBiosource | 0.1mg | 445 EUR |
West Nile Virus Envelope Antibody |
|||
MBS150612-5x01mg | MyBiosource | 5x0.1mg | 1965 EUR |
West Nile Virus Envelope Antibody |
|||
MBS150867-01mg | MyBiosource | 0.1mg | 445 EUR |
West Nile Virus Envelope Antibody |
|||
MBS150867-5x01mg | MyBiosource | 5x0.1mg | 1965 EUR |
West Nile Virus Envelope Antibody |
|||
MBS150323-01mg | MyBiosource | 0.1mg | 445 EUR |
West Nile Virus Envelope Antibody |
|||
MBS150323-5x01mg | MyBiosource | 5x0.1mg | 1965 EUR |
Anti-E (West Nile Virus) Antibody |
|||
MBS432133-01mg | MyBiosource | 0.1mg | 355 EUR |
Anti-E (West Nile Virus) Antibody |
|||
MBS432133-5x01mg | MyBiosource | 5x0.1mg | 1440 EUR |
West Nile Virus (WNV-NS1) Antibody |
|||
MBS569183-1mg | MyBiosource | 1mg | 650 EUR |
West Nile Virus (WNV-NS1) Antibody |
|||
MBS569183-5x1mg | MyBiosource | 5x1mg | 2735 EUR |
West Nile Virus (WNV-NS1) Antibody |
|||
MBS569185-1mg | MyBiosource | 1mg | 650 EUR |
West Nile Virus (WNV-NS1) Antibody |
|||
MBS569185-5x1mg | MyBiosource | 5x1mg | 2735 EUR |
West Nile Virus (WNV-NS1) Antibody |
|||
MBS569186-1mg | MyBiosource | 1mg | 650 EUR |
West Nile Virus (WNV-NS1) Antibody |
|||
MBS569186-5x1mg | MyBiosource | 5x1mg | 2735 EUR |